Regeneron Pharmaceuticals
A leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases.
HQ location
Town of Greenburgh, United States
Website
Launch date
Employees
Market cap
$56.3b
Enterprise value
$50.6b
Share price
$525.00 REGN
Recent deals
Corporate Venture Fund
No columns specified